Literature DB >> 27062151

Platelet count and transfusion requirements during moderate or severe postpartum haemorrhage.

R M Jones1, L de Lloyd1, E J Kealaher1, G J Lilley1, E Precious2, D Burckett St Laurent1, V Hamlyn1, R E Collis1, P W Collins2.   

Abstract

Limited data exist on platelet transfusion during postpartum haemorrhage. We retrospectively analysed a consecutive cohort from a single centre of 347 women with moderate or severe postpartum haemorrhage, transfused according to national guidelines. Twelve (3%) women required a platelet transfusion. There were no differences between women who did and did not receive platelets with respect to age, mode of initiation of labour or mode of delivery. Women receiving a platelet transfusion had a lower median (IQR [range]) platelet count at study entry than women who did not receive platelets before haemorrhage (135 (97-175 [26-259])×10(9) .l(-1) vs 224 (186-274 [91-1006])×10(9) .l(-1) ), respectively), and at diagnosis of postpartum haemorrhage (median 114 (78-153 [58-238])×10(9) .l(-1) vs 193 (155-243 [78-762])×10(9) .l(-1) respectively). Six women were thrombocytopenic pre-delivery. The cause of haemorrhage that was associated with the highest rate of platelet transfusion was placental abruption, with three of 14 women being transfused. If antenatal thrombocytopenia or consumptive coagulopathy were not present, platelets were only required for haemorrhage > 5000 ml. Early formulaic platelet transfusion would have resulted in many women receiving platelets unnecessarily. Using current guidelines, the need for platelet transfusion is uncommon without antenatal thrombocytopenia, consumptive coagulopathy or haemorrhage > 5000 ml. We found no evidence to support early fixed-ratio platelet transfusion.
© 2016 The Association of Anaesthetists of Great Britain and Ireland.

Entities:  

Keywords:  platelets; postpartum haemorrhage; thrombocytopenia; transfusion

Mesh:

Year:  2016        PMID: 27062151     DOI: 10.1111/anae.13448

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  4 in total

1.  Reduction in massive postpartum haemorrhage and red blood cell transfusion during a national quality improvement project, Obstetric Bleeding Strategy for Wales, OBS Cymru: an observational study.

Authors:  Sarah F Bell; Rachel E Collis; Philip Pallmann; Christopher Bailey; Kathryn James; Miriam John; Kevin Kelly; Thomas Kitchen; Cerys Scarr; Adam Watkins; Tracey Edey; Elinore Macgillivray; Kathryn Greaves; Ingrid Volikas; James Tozer; Niladri Sengupta; Iolo Roberts; Claire Francis; Peter W Collins
Journal:  BMC Pregnancy Childbirth       Date:  2021-05-15       Impact factor: 3.007

2.  Statistical analysis plan for the WOMAN-ETAPlaT study: Effect of tranexamic acid on platelet function and thrombin generation.

Authors:  Kastriot Dallaku; Haleema Shakur; Phil Edwards; Danielle Beaumont; Ian Roberts; Sumaya Huque; Maria Delius; Ulrich Mansmann
Journal:  Wellcome Open Res       Date:  2016-12-15

3.  Prednisone plus IVIg compared with prednisone or IVIg for immune thrombocytopenia in pregnancy: a national retrospective cohort study.

Authors:  Xiao-Lu Zhu; Ru Feng; Qiu-Sha Huang; Mei-Ying Liang; Ming Jiang; Hui Liu; Yi Liu; Hong-Xia Yao; Lei Zhang; Shen-Xian Qian; Tong-Hua Yang; Jing-Yu Zhang; Xu-Liang Shen; Lin-Hua Yang; Jian-Da Hu; Ren-Wei Huang; Zhong-Xing Jiang; Jing-Wen Wang; Hong-Yu Zhang; Zhen Xiao; Si-Yan Zhan; Hui-Xin Liu; Xing-Lin Wang; Ying-Jun Chang; Yu Wang; Yuan Kong; Lan-Ping Xu; Kai-Yan Liu; Xiao-Hong Zhang; Cheng-Hong Yin; Yue-Ying Li; Qian-Fei Wang; Jian-Liu Wang; Xiao-Jun Huang; Xiao-Hui Zhang
Journal:  Ther Adv Hematol       Date:  2022-04-29

4.  Haematological and fibrinolytic status of Nigerian women with post-partum haemorrhage.

Authors:  Ian Roberts; Haleema Shakur; Bukola Fawole; Modupe Kuti; Oladapo Olayemi; Adenike Bello; Olayinka Ogunbode; Taiwo Kotila; Chris O Aimakhu; Tolulase Olutogun; Beverley J Hunt; Sumaya Huque
Journal:  BMC Pregnancy Childbirth       Date:  2018-05-09       Impact factor: 3.007

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.